menu search

TBIO / Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery Read More
Posted: Jun 6 2023, 03:00
Author Name: GlobeNewsWire
Views: 102216

TBIO News  

Telesis Bio to Present at Jefferies Healthcare Conference 2023

By GlobeNewsWire
June 8, 2023

Telesis Bio to Present at Jefferies Healthcare Conference 2023

SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announ more_horizontal

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

By GlobeNewsWire
June 6, 2023

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery Showcasing full suite of molecular biology workflow more_horizontal

Telesis Bio to Present at SynBioBeta 2023

By GlobeNewsWire
May 23, 2023

Telesis Bio to Present at SynBioBeta 2023

Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery Highlighting application of the Molecula more_horizontal

Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 11, 2023

Telesis Bio (TBIO) Reports Q1 Loss, Misses Revenue Estimates

Telesis Bio (TBIO) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of more_horizontal

Telesis Bio, Inc. (TBIO) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 25, 2023

Telesis Bio, Inc. (TBIO) Q4 2022 Earnings Call Transcript

Telesis Bio, Inc. (NASDAQ:TBIO ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Jen Carroll - VP, IR Todd Nelson - Pr more_horizontal

Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
March 21, 2023

Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates

Telesis Bio (TBIO) delivered earnings and revenue surprises of 12.50% and 5.21%, respectively, for the quarter ended December 2022. Do the numbers hol more_horizontal

Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023

By GlobeNewsWire
March 9, 2023

Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023

SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today ann more_horizontal


Search within

Pages Search Results: